Pulmonary Disease Due to Nontuberculous Mycobacteria: Current State and New Insights
- PMID: 26225805
- PMCID: PMC4665741
- DOI: 10.1378/chest.15-0458
Pulmonary Disease Due to Nontuberculous Mycobacteria: Current State and New Insights
Abstract
Since pulmonary nontuberculous mycobacteria (PNTM) lung disease was last reviewed in CHEST in 2008, new information has emerged spanning multiple domains, including epidemiology, transmission and pathogenesis, clinical presentation, diagnosis, and treatment. The overall prevalence of PNTM is increasing, and in the United States, areas of highest prevalence are clustered in distinct geographic locations with common environmental and socioeconomic factors. Although the accepted paradigm for transmission continues to be inhalation from the environment, provocative reports suggest that person-to-person transmission may occur. A panoply of host factors have been investigated in an effort to elucidate why infection from this bacteria develops in ostensibly immunocompetent patients, and there has been clarification that immunocompetent patients exhibit different histopathology from immunocompromised patients with nontuberculous mycobacteria infection. It is now evident that Mycobacterium abscessus, an increasingly prevalent cause of PNTM lung disease, can be classified into three separate subspecies with differing genetic susceptibility or resistance to macrolides. Recent publications also raise the possibility of improved control of PNTM through enhanced adherence to current treatment guidelines as well as new approaches to treatment and even prevention. These and other recent developments and insights that may inform our approach to PNTM lung disease are reviewed and discussed.
Figures
Comment in
-
Genesis of the Nodular Bronchiectasis Phenotype of Pulmonary Disease Due to Nontuberculous Mycobacteria.Chest. 2016 Apr;149(4):1113. doi: 10.1016/j.chest.2015.12.042. Chest. 2016. PMID: 27055711 No abstract available.
References
-
- Glassroth J. Pulmonary disease due to nontuberculous mycobacteria. Chest. 2008;133(1):243-251. - PubMed
-
- Pitchenik AE. PPD-tuberculin and PPD-Battey dual skin testing of hospital employees and medical students. South Med J. 1978;71(8):917-918, 922. - PubMed
-
- Griffith DE, Aksamit T, Brown-Elliott BA, et al. ; ATS Mycobacterial Diseases Subcommittee; American Thoracic Society; Infectious Disease Society of America. An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases [published correction appears in Am J Respir Crit Care Med. 2007;175(7):744-745]. Am J Respir Crit Care Med. 2007;175(4):367-416. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
